Adjunctive vortioxetine for SSRI-resistant major depressive disorder: a "real-world" chart review study.
Domenico de BerardisMichele FornaroAnnalisa AnastasiaFederica VellanteLuigi OlivieriGabriella RapiniNicola SerroniLaura OrsoliniAlessandro ValcheraAlessandro CaranoCarmine TomasettiAntonio VentriglioMassimiliano BustiniMaurizio PompiliGianluca SerafiniGiampaolo PernaFelice IasevoliGiovanni MartinottiMassimo Di GiannantonioPublished in: Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999) (2020)
Adjunctive vortioxetine may be useful and well-tolerated in stage I treatment-resistant depression. However, the limitations of this study (such as small sample size, absence of randomization and control group, retrospective design, etc.) must be considered.